Restricted transgene expression in the brain with cell-type specific neuronal promoters.

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Accès restreint UNIL
Etat: Public
Version: de l'auteur⸱e
Document(s) secondaire(s)
Télécharger: 5_22934828_LPostprint.pdf (1655.86 [Ko])
Etat: Public
Version: de l'auteur⸱e
ID Serval
serval:BIB_B17434CC555F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Restricted transgene expression in the brain with cell-type specific neuronal promoters.
Périodique
Human Gene Therapy Methods
Auteur⸱e⸱s
Delzor A., Dufour N., Petit F., Guillermier M., Houitte D., Auregan G., Brouillet E., Hantraye P., Déglon N.
ISSN
1946-6544 (Electronic)
Statut éditorial
Publié
Date de publication
2012
Peer-reviewed
Oui
Volume
23
Numéro
4
Pages
242-254
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't Publication Status: ppublish
Résumé
Tissue-targeted expression is of major interest for studying the contribution of cellular subpopulations to neurodegenerative diseases. However, in vivo methods to investigate this issue are limited. Here, we report an analysis of the cell specificity of expression of fluorescent reporter genes driven by six neuronal promoters, with the ubiquitous phosphoglycerate kinase 1 (PGK) promoter used as a reference. Quantitative analysis of AcGFPnuc expression in the striatum and hippocampus of rodents showed that all lentiviral vectors (LV) exhibited a neuronal tropism; however, there was substantial diversity of transcriptional activity and cell-type specificity of expression. The promoters with the highest activity were those of the 67 kDa glutamic acid decarboxylase (GAD67), homeobox Dlx5/6, glutamate receptor 1 (GluR1), and preprotachykinin 1 (Tac1) genes. Neuron-specific enolase (NSE) and dopaminergic receptor 1 (Drd1a) promoters showed weak activity, but the integration of an amplification system into the LV overcame this limitation. In the striatum, the expression profiles of Tac1 and Drd1a were not limited to the striatonigral pathway, whereas in the hippocampus, Drd1a and Dlx5/6 showed the expected restricted pattern of expression. Regulation of the Dlx5/6 promoter was observed in a disease condition, whereas Tac1 activity was unaffected. These vectors provide safe tools that are more selective than others available, for the administration of therapeutic molecules in the central nervous system (CNS). Nevertheless, additional characterization of regulatory elements in neuronal promoters is still required.
Mots-clé
Animals, Brain/metabolism, Brain/pathology, Genes, Reporter, Genetic Vectors/genetics, Genetic Vectors/metabolism, Glutamate Decarboxylase/genetics, Glutamate Decarboxylase/metabolism, Hippocampus/metabolism, Homeodomain Proteins/genetics, Homeodomain Proteins/metabolism, Lentivirus/genetics, Male, Mice, Neurons/metabolism, Neurons/pathology, Phosphoglycerate Kinase/genetics, Phosphoglycerate Kinase/metabolism, Phosphopyruvate Hydratase/genetics, Phosphopyruvate Hydratase/metabolism, Promoter Regions, Genetic/genetics, Protein Precursors/genetics, Protein Precursors/metabolism, Rats, Receptors, AMPA/genetics, Receptors, AMPA/metabolism, Receptors, Dopamine D1/genetics, Receptors, Dopamine D1/metabolism, Tachykinins/genetics, Tachykinins/metabolism, Transcription, Genetic, Transduction, Genetic
Pubmed
Web of science
Création de la notice
14/09/2012 16:26
Dernière modification de la notice
20/08/2019 16:20
Données d'usage